Complete, faithful version of the report. For a concise, organized read go to the readable version.

Compressive radial neuropathy ("Saturday night palsy") and wrist drop: pathophysiology, recovery, diagnosis and evidence-based interventions

TL;DR

• "Saturday night palsy" (compression of the radial nerve at the spiral groove of the humerus) is typically a neurapraxia (conduction block from focal demyelination, Sunderland grade I), with an excellent prognosis: in clinical series of pure compression essentially all patients followed up recover completely — Arnold et al. (Muscle & Nerve 2012, n=51) report complete recovery in all 23 patients with follow-up, on average in 3.4 months, and conclude that there is a "good prognosis in essentially all patients with acute compressive radial neuropathies".
• The intervention with the best evidence is conservative: a wrist extension splint (cock-up), maintenance of the passive range of motion, occupational therapy; EMG/conduction studies should be performed after 3–4 weeks to stage the damage. Surgery is reserved for cases without recovery (typically after 3–6 months) or with known transection.
• Many promoted interventions (B-group vitamins, vitamin B12, alpha-lipoic acid, citicoline, acetyl-L-carnitine, laser/LLLT, ultrasound, TENS, electrical stimulation) have weak, indirect or absent evidence for compressive radial neuropathy specifically: the meta-analysis by Bula-Oyola et al. (PLOS One 2021, 38 studies, low/very low GRADE) finds only "limited favourable evidence for efficacy of electrophysical modalities" and most of the other data come from diabetic neuropathy, carpal tunnel or animal models.

Key Findings

1. Pathophysiology. Acute external compression of the radial nerve typically produces a neurapraxia (conduction block from focal demyelination ± ischemia) — Seddon neurapraxia / Sunderland grade I. In a minority of more severe or prolonged cases, secondary axonal loss is added (axonotmesis / Sunderland II–III). Neurotmesis (complete transection, Sunderland V) is not typical of compression and requires surgery.
2. Prognosis and timing. Neurapraxia: recovery in weeks (typically 6–8 weeks, up to 2–3 months). Axonotmesis: slow recovery through axonal regeneration at ~1 mm/day (months). Neurotmesis: no spontaneous recovery. Series on pure compression report complete recovery in ~100% of patients followed up.
3. Diagnosis. Clinical examination (wrist drop with triceps spared, deficit of wrist/finger/thumb extensors, sensory loss over the dorsum of the hand) + EMG/NCS at 3–4 weeks (to give Wallerian degeneration time to manifest on needle EMG and to distinguish conduction block vs axonal loss). High-resolution ultrasound and MRI/neurography are useful to localize and identify structural causes.
4. Evidence-based interventions. Splint + physiotherapy/passive ROM = standard, evidence mostly observational/expert opinion but rationally robust. Brief perioperative electrical stimulation (1 h, 20 Hz) has positive RCTs but only in a surgical setting (carpal tunnel, digital nerve, cubital nerve), not on the compressive radial nerve. Surgery (decompression/neurolysis, graft, nerve or tendon transfer) for failure of recovery.
5. What lacks solid evidence. Neurotrophic supplements, laser, therapeutic ultrasound, TENS and corticosteroids lack quality direct evidence for speeding the motor recovery of compressive radial neuropathy.

Details

1. Pathophysiology: the Seddon and Sunderland classifications

The Seddon classification (1942/1943) divides peripheral nerve damage into three categories, expanded by Sunderland (1951) into five grades:

• Neurapraxia (Seddon) = Sunderland grade I. Focal conduction block from demyelination and/or ischemia, without loss of axonal continuity. The structures (endoneurium, perineurium, epineurium) remain intact. Characteristic of entrapment neuropathies and "pressure palsies". On electrodiagnostics: CMAP and SNAP evocable by stimulating distal to the lesion, but conduction block on proximal stimulation; no axonal degeneration; no Tinel sign. Once the segment is remyelinated, motor and sensory recovery is complete.
• Axonotmesis (Seddon) = Sunderland II–III (–IV). Damage to the axon with distal Wallerian degeneration, but (at least partial) preservation of the connective sheaths. Grade II has an intact endoneurium (complete recovery possible); grade III has endoneurial disorganization (variable/incomplete recovery); grade IV (interrupted perineurium) often requires surgery. Typical of stretch/contusion/severe-compression injuries.
• Neurotmesis (Seddon) = Sunderland V. Complete transection of all structures. No spontaneous recovery; surgery mandatory.

Which type of damage in Saturday night palsy? Acute external compression at the spiral groove typically produces a neurapraxia (conduction block/slowing from focal demyelination). Trojaborg's classic electrophysiological study (J Neurol Neurosurg Psychiatry 1970, n=58) documented "considerable slowing of conduction in both motor and sensory fibres across the presumed site of the lesion with return to normality within six to eight weeks… these observations suggest that local demyelination is the cause of nerve palsy". However, a significant proportion of clinically followed cases also show secondary axonal loss (active denervation on needle EMG), while still carrying an excellent prognosis; in the study by Kwon et al. (Am J Phys Med Rehabil 2024, n=23) compression was the most common cause of the conduction-block pattern (~43% block, ~43% axonal, ~9% mixed, but the axonal cases were predominantly iatrogenic). Prognostic implications: neurapraxia = rapid and complete recovery; added axonal loss = slower recovery (months) but still generally good in pure compression.

2. Recovery times and prognostic factors

Neurapraxia: remyelination in weeks. Trojaborg documented a return to normal in 6–8 weeks. Several sources indicate recovery of acute radial compression in 2–12 weeks.

Axonotmesis: axonal regeneration proceeds at about 1 mm/day (~1 inch/month), with a slightly higher rate for proximal segments (2–3 mm/day) and lower distally. It follows that recovery of the most proximally innervated muscles (brachioradialis, ECRL) can take ~6 months.

Specific data on pure compression (not fracture-related):

• Arnold et al. (Muscle & Nerve 2012, n=51, retrospective, 10 years): among the 23 patients (45%) with available follow-up, all had complete recovery; mean duration from onset to resolution 3.4 months. Conclusion: "good prognosis in essentially all patients with acute compressive radial neuropathies".
• Kim et al. (J Clin Neurol 2015, n=39): all 33 patients with follow-up had complete recovery, mean time 46.8 ± 34.3 days (~6–7 weeks); partial conduction block in 17/39 (~44%); "the decrease in CMAP area between the arm and Erb's point was an independent predictor for recovery time" (greater axonal loss → longer recovery).
• Han et al. (J Korean Neurosurg Soc 2014, n=25, "Saturday night palsy"): improvement began on average at 2.4 weeks; good prognosis within a few weeks.

Recovery in humeral fractures (cautious extrapolation). The most recent systematic review (PMC7736027, period 2000–2018, 4,972 humeral fractures) reports an incidence of primary radial palsy of 12.2% and a "high rate of spontaneous radial nerve palsy recovery (85%)", with ~70.7% recovering spontaneously within 6 months. The updated Mangan/JAAOS 2020 review reports spontaneous recovery of 77.2% in those treated non-surgically; early exploration (<3 weeks) 89.8%; late exploration (>8 weeks) 68.1%. Mean time to recovery ~6.1 months (range 3.4–12). These data concern fracture-related injuries, mechanically different from pure external compression.

Favorable prognostic factors: conduction block without axonal loss; low-energy trauma; young age; early recovery of the brachioradialis. Unfavorable: marked axonal loss (reduced CMAP), denervation without reinnervation on EMG, age >50, smoking, associated vascular injuries. Early electrophysiological sign of reinnervation: the EMG can precede the clinical signs of reinnervation by up to 4 weeks (e.g. reinnervation potentials on the extensors before voluntary movement).

3. Diagnosis

Clinical examination. Wrist drop (dropping of the wrist) with weakness of the wrist, finger and thumb extensors; triceps spared in lesions at the spiral groove (the triceps innervation is proximal); sensory loss over the dorsum of the hand/first web space. The brachioradialis is the first muscle to recover. Posterior interosseous nerve (PIN) palsy is distinguished by preservation of elbow extension and sensation.

EMG/NCS — timing. It is recommended to wait 3–4 weeks from onset: Wallerian degeneration takes time to manifest. The serial data of Chaudhry & Cornblath (Muscle Nerve 1992) show: motor amplitude reduced by 50% at 3–5 days and absent by day 9; sensory amplitude reduced by 50% at 7 days, absent by day 11; denervation potentials (fibrillations, positive waves) appear 10–14 days after the injury, with better yield at 2–3 weeks. Performing the EMG too early can underestimate the extent of axonal damage and fail to distinguish neurapraxia from axonotmesis. Functions: localize the lesion, quantify axonal loss vs conduction block, monitor reinnervation.

Imaging. High-resolution nerve ultrasound (HRUS): fast, identifies nerve enlargement, masses (ganglia, lipomas), discontinuities; in a prospective study of 180 peripheral nerves (131 patients; Insights into Imaging 2019, DOI 10.1186/s13244-019-0787-6) HRUS showed sensitivity 87.33% and accuracy 86.11%, proving "five times quicker" than MRI (PD fat-sat MRI: accuracy 93.89%). MRI/neurography (3T): excellent anatomical detail, shows an enlarged nerve with T2 hyperintensity upstream of the compression, "hourglass" constrictions, fascicular disorganization; useful for surgical planning. X-ray to rule out fractures/bone lesions.

4. Interventions with scientific support (critical appraisal by level of evidence)

a) Splint (cock-up / wrist extension splint), physiotherapy, ROM, occupational therapy.

• Rationale and standard of care. The wrist extension splint (and dynamic splints that allow passive ROM) maintains the functional position, prevents contractures and lengthening of the extensors while awaiting reinnervation.
• Evidence: mostly case series, narrative reviews and expert opinion (low formal level of evidence), but with strong biomechanical rationale and universal clinical consensus. The EFORT review (Bumbasirevic et al. 2016) emphasizes that the most important aspect of conservative treatment is maintaining the full passive range in all affected joints.
• The meta-analysis by Bula-Oyola et al. (PLOS One 2021, 38 studies, low/very low GRADE quality) on radial/ulnar/median neuropathies found that splints were superior to electrophysical modalities, but no result reached the minimal clinically important difference (MCID); overall evidence "limited favourable".

b) Corticosteroids (oral/injected).

• Direct evidence for compressive radial neuropathy: essentially absent. A systematic review (Frontiers in Neurology 2024, MacKay et al.) concludes that, although steroids reduce inflammation and in animal models favor myelination/regeneration, "there is still a gap in the literature as to whether they have a defined therapeutic use in the treatment of peripheral nerve injury". Perineural steroids have some evidence for neuropathic pain (meta-analysis, Can J Anesth 2015), not for motor recovery.

c) B-group vitamins, B12, alpha-lipoic acid, citicoline, acetyl-L-carnitine, uridine.

• Most of the evidence concerns diabetic neuropathy or carpal tunnel, not compressive radial neuropathy. Alpha-lipoic acid has positive RCT meta-analyses in diabetic neuropathy (symptom reduction, improved conduction velocity), but often of low quality (DARE/NBK114396: "the evidence was mainly of poor quality"). B12 has solid evidence only in cases of documented deficiency (review of 10 RCTs: supplementation improves symptoms in overt deficiency, but not in subclinical deficiency). Acetyl-L-carnitine has positive RCTs in diabetic/chemotherapy-induced neuropathy and one RCT in carpal tunnel, but no study in compressive radial neuropathy. Citicoline and uridine have minimal/preclinical evidence.
• Conclusion: for compressive radial neuropathy without nutritional deficiency, these supplements are extrapolations unsupported by direct evidence.

d) Electrical stimulation, FES, TENS, laser (LLLT/PBM), ultrasound.

• Brief perioperative electrical stimulation (1 h, 20 Hz): has the best evidence among the electrical modalities — positive RCTs (Gordon et al. 2010, Exp Neurol, carpal tunnel; Wong et al. 2015, Ann Neurol, digital nerve; Power et al. 2020, Neurosurgery, cubital tunnel) show accelerated reinnervation (increased MUNE). BUT: applied intraoperatively after surgical repair/decompression, not in non-operated compressive radial neuropathy. An extrapolation not validated for Saturday night palsy.
• TENS: Cochrane (Gibson et al. 2017, 15 studies, 724 participants) — "very low" quality evidence, impossible to establish with confidence whether it is effective for neuropathic pain; no role in motor recovery.
• LLLT/photobiomodulation: mostly preclinical evidence (animal models); clinical systematic reviews are of low quality and the results not clinically significant (Bula-Oyola, PLOS One 2021).
• Therapeutic ultrasound: same meta-analysis, low quality, no clinically significant benefit.

e) Surgery (decompression/neurolysis, exploration, graft, nerve/tendon transfer).

• Indications: known transection (open wounds, lacerations), no clinical/electrophysiological recovery after a period of observation (typically 3–6 months), or identified structural causes. For pure Saturday night palsy, surgery is rarely necessary.
• For fracture-associated palsy: early exploration (<3 weeks) if open fracture, high energy, spiral fractures with fragments — in a series of 24 operated patients (Acta Orthop Traumatol Turc, PMID 26874634) "nerve compression between the fracture fragments in seven patients (29.1%)" was found, the majority (n=6) with spiral fractures, with radial recovery in 95.8% — or secondary palsy after fixation.
• Late reconstruction: nerve grafting should preferably be done before 6 months; nerve transfers up to ~10 months; beyond 10–12 months, tendon transfers are the gold standard. Motor end-plate degeneration becomes irreversible at 12–18 months.
• Tendon vs nerve transfers: the systematic review by Jain et al. (Hand (N Y) 2024;19(3):343–351, DOI 10.1177/15589447221150516; 29 studies, 754 patients) found that tendon transfers have the highest rate of good outcomes (82% good, 9% poor) versus nerve grafting (32% good, 39% poor), and "tendon transfers were superior to nerve grafts and nerve transfers for restoration of wrist extension"; they should be considered first line for irreparable isolated radial palsy. An earlier review (Compton et al. 2018, JAAOS Global, level III) had not found a clearly superior technique.

5. What does NOT have solid evidence or is ineffective

• "Neurotrophic" supplements (B12 without deficiency, alpha-lipoic acid, acetyl-L-carnitine, citicoline, uridine) to speed the motor recovery of compressive radial neuropathy: no direct RCT; evidence extrapolated from other neuropathies (diabetic, chemotherapy-induced, carpal tunnel).
• Low-level laser, therapeutic ultrasound, TENS: low/very low quality clinical evidence, not clinically significant; TENS at most for pain (Cochrane: "very low quality evidence").
• Corticosteroids for motor recovery: inadequate evidence; an explicit gap in the literature.
• Transcutaneous/non-surgical electrical stimulation in Saturday night palsy: not validated; the positive RCTs concern intraoperative perioperative stimulation after nerve surgery.
• PRP (platelet-rich plasma): case reports only (e.g. ultrasound-guided intraneural injection).
• It should be noted that most of the literature on compressive neuropathies concerns the median (carpal tunnel) and ulnar nerves; specific evidence on the radial nerve is limited to small retrospective series, without RCTs.

Recommendations

1. Acute phase (weeks 0–3): clinical diagnosis of wrist drop, rule out a structural cause/fracture (X-ray; ultrasound if a mass or transection is suspected). Start a wrist extension splint (cock-up) ± dynamic finger support, and daily passive ROM of the wrist and fingers to prevent contractures. Educate the patient about the generally favorable prognosis (recovery expected in weeks–a few months in pure compression).
2. Weeks 3–4: perform EMG/NCS to stage (conduction block vs axonal loss) and establish a baseline. Pure conduction block → recovery expected in weeks; reduced CMAP/denervation → recovery in months. A benchmark that changes management: the reduction in CMAP area between the arm and Erb's point predicts a longer recovery (Kim 2015).
3. Follow-up: serial clinical monitoring (return of brachioradialis → wrist extensors → fingers). Repeat the EMG at ~3 months if there is no clinical recovery; EMG signs of reinnervation can precede the clinical ones by ~4 weeks and justify watchful waiting.
4. Thresholds for surgery: known transection or a correctable structural cause → prompt exploration/decompression. No sign of clinical or electrophysiological recovery at 3–6 months → consider exploration/neurolysis. No recovery at 10–12 months → tendon transfers (first line for restoring wrist extension, 82% good outcomes).
5. Avoid promising benefits from supplements, laser, ultrasound, TENS or steroids to speed motor recovery: not supported by direct evidence. B12 should be supplemented only if a deficiency is documented. Correcting modifiable factors (smoking cessation, glycemic control, avoiding further compression/alcohol abuse) has a general rationale and improves the prognosis.

Caveats

• Direct evidence on compressive radial neuropathy ("Saturday night palsy") is limited to small retrospective series (maximum n=51), with no RCTs or large prospective cohorts; the "100%" recovery rates refer only to the patients actually followed up (relevant loss to follow-up: Arnold 45%, Kim 33/39).
• Much of the data on interventions is extrapolated from diabetic neuropathy, carpal tunnel or animal models, and should be applied to the radial nerve with caution; every extrapolation is flagged as such in the text.
• Recovery times vary according to the proportion of axonal damage vs neurapraxia, not always clinically determinable at onset; this is why EMG at 3–4 weeks is central to the prognosis.
• The figures on fracture-related recovery (85% spontaneous; 77–90% depending on surgical strategy) are not directly transferable to pure external compression, due to differences in mechanism and severity.
• Some widely cited figures (e.g. denervation percentages of 60–90% in Saturday night palsy series) come from reviews that refer back to older clinical series whose primary source was not directly verified in this research.

Main peer-reviewed sources cited: Arnold et al. Muscle & Nerve 2012; Kim et al. J Clin Neurol 2015; Han et al. J Korean Neurosurg Soc 2014; Trojaborg, JNNP 1970; Kwon et al. Am J Phys Med Rehabil 2024; Chaudhry & Cornblath, Muscle Nerve 1992; Bumbasirevic et al. EFORT Open Rev 2016; Bula-Oyola et al. PLOS One 2021; Jain et al. Hand (N Y) 2024; Compton et al. JAAOS Global 2018; Gibson et al. Cochrane 2017; Gordon et al. Exp Neurol 2010; Wong et al. Ann Neurol 2015; Power et al. Neurosurgery 2020; MacKay et al. Front Neurol 2024; humeral fracture systematic review PMC7736027 and JAAOS 2020; Insights into Imaging 2019 (HRUS).